AGM/EGMJun 25, 2026, 07:01 AM
RedHill Biopharma Schedules AGM for July 28; Key Board Votes
AI Summary
RedHill Biopharma Ltd. announced its Annual General Meeting of Shareholders to be held on July 28, 2026. Key agenda items include the re-appointment of auditors, the re-election of Mr. Rick D. Scruggs and Dr. Shmuel Cabilly to the Board of Directors for three-year terms, and the approval of Mr. Dror Ben-Asher to serve concurrently as Chairman of the Board and Chief Executive Officer for three years. Shareholders will also review the company's financial statements for the fiscal year ended December 31, 2025.
Key Highlights
- Annual General Meeting (AGM) scheduled for July 28, 2026, at 3:00 p.m. Israel time.
- Shareholders to vote on re-appointment of Kesselman & Kesselman as auditors for 2026.
- Proposal to re-elect Mr. Rick D. Scruggs to the Board of Directors for a three-year term.
- Proposal to re-elect Dr. Shmuel Cabilly to the Board of Directors for a three-year term.
- Proposal to approve Mr. Dror Ben-Asher as Chairman of the Board and CEO for three years.
- Record date for shareholders entitled to vote at the AGM is June 23, 2026.
- Shareholders will have an opportunity to review and ask questions regarding 2025 financial statements.
Price Impact
More from RDHL